Navigation Links
Haemonetics' Chairman and CEO Adopts 10b5-1 Stock Trading Plan

BRAINTREE, Mass., May 6 /PRNewswire-FirstCall/ -- Haemonetics Corporation announced today that Brad Nutter, Chairman and CEO, has adopted a pre-arranged stock trading plan under Rule 10b5-1 of the Securities Exchange Act of 1934.

Rule 10b5-1 plans allow executives to adopt a pre-arranged stock trading plan to buy or sell a specified number of shares of the company's stock. Under the plan, Mr. Nutter will exercise only the new-hire stock options granted to him in 2003 when he was hired by Haemonetics as President and CEO. In 2007, Mr. Nutter was promoted to the position of Chairman of the Board of Directors and CEO. Mr. Nutter is entering into the plan for portfolio diversification purposes.

Mr. Nutter remains in compliance with Haemonetics' executive stock ownership plan.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at


Julie Fallon

Tel. (781) 356-9517

Alternate Tel. (617) 320-2401

SOURCE Haemonetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009
2. Haemonetics Sets Date for Fourth Quarter and Fiscal Year End 2008 Earnings Release and Conference Call - May 1, 2008
3. Haemonetics(R) Software Solutions to Launch Application for Workflow Optimization in Blood Collection Centers
4. Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales
5. Haemonetics Sets Date for Q3FY08 Earnings Release and Conference Call - January 31, 2008
6. Haemonetics Appoints Executive Leadership of European Operations
7. Keiko Hattori Joins Haemonetics as President of Haemonetics Japan
8. Haemonetics Webcast Presentation
9. Chrysler LLC Chairman and CEO Bob Nardelli and Chrysler Foundation Recognized by Larry King Cardiac Foundation for Dedication to Improving Lives of Others
10. Statement by H.E. Jakaya Mrisho Kikwete, President of the United Republic of Tanzania, and Chairman of the African Union, in Response to UN-SG Call to Action on Malaria
11. AMN Healthcare Services Elects Douglas D. Wheat as Chairman of the Board
Post Your Comments:
(Date:11/28/2015)... ... November 28, 2015 , ... Trying to relax on a couch can ... "I conceived of this design due to personal experience with a bad back," he ... relaxation and convenience, as well as increases support. It also makes it easier to ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... According ... carried out by the University of Toronto and the University of British Columbia suggested ... hospitalizations for head injuries. The article explains that part of the reason for the ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
(Date:11/27/2015)... ... 27, 2015 , ... Consistent with the Radiology Business ... Better Radiology Marketing Programs meeting will showcase some of the best 2015 ... Caesars Palace in Las Vegas with a pre-conference session on a collaborative approach ...
(Date:11/27/2015)... ... November 27, 2015 , ... CBD College is proud to ... Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. CBD College is honored ... one of twelve colleges and universities in the state of California make the cut. ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 ) ... "Radioimmunoassay Market by Type (Reagents & Kits, ... Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), ... report to their offering. --> ... of the "Radioimmunoassay Market by Type ...
(Date:11/25/2015)... 2015 ... "Global Brain Monitoring Devices Market 2015-2019" ... ) has announced the addition ... Market 2015-2019" report to their offering. ... ) has announced the addition of ...
(Date:11/25/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... the United States (U.S.) Food ... candidate to Humira ® (adalimumab). Amgen believes this ... the FDA and represents Amgen,s first BLA submission using ... , M.D., executive vice president of Research and Development ...
Breaking Medicine Technology: